Kammerle Schneider

Program Leader, Malaria & Neglected Tropical Diseases & Director, Center for Malaria Control & Elimination at PATH

Kammerle Schneider

Kammerle Schneider

Program Leader, Malaria & Neglected Tropical Diseases & Director, Center for Malaria Control & Elimination at PATH

Biography

Kammerle Schneider is the leader of PATH’s Malaria and Neglected Tropical Diseases program and the director of PATH’s Center for Malaria Control and Elimination. Building on our unparalleled portfolio of malaria tools, approaches, and expertise, she directs our work to eliminate and ultimately eradicate both Plasmodium falciparum and Plasmodium vivax malaria. She also oversees part of a coordinated global effort to stamp out 17 neglected tropical diseases, including onchocerciasis and soil-transmitted helminths.

Kammerle joined PATH in 2011 as a senior policy officer for PATH’s Malaria Control and Elimination Partnership in Africa (MACEPA) and then took on the role of deputy director of the program. She also served as deputy director of PATH’s Center for Malaria Control and Elimination, which encompasses the entirety of PATH’s work in malaria—from insecticide-treated bednets to groundbreaking vaccines to improved diagnostics and drug treatments. During this time, she worked extensively to help build the malaria portfolio and to oversee MACEPA’s policy and analytics team. She was responsible for analyzing and influencing changes in policy, strategy, and systems to accelerate the introduction and scale up of new tools and approaches for malaria burden reduction and elimination.

Before joining PATH, Kammerle worked with the International AIDS Vaccine Initiative where she managed policy research and advocacy activities to accelerate the development of, and future global access to, a preventive AIDS vaccine. She also served as the assistant director of the Global Health Program at the Council on Foreign Relations.

Kammerle holds a master of international affairs degree from Columbia University and a bachelor of arts from the University of Washington. She is currently a PhD candidate at the London School of Hygiene & Tropical Medicine.

Overview
RelSci Relationships

698

Contact Data
Trying to get in touch with Kammerle Schneider? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Kammerle Schneider likely has professional access to. A relationship does not necessarily indicate a personal connection.

Senior China Strategy Advisor & Interim Director at Bill & Melinda Gates Foundation

Relationship likelihood: Strong

Director, Office of Research Affairs at PATH

Relationship likelihood: Strong

Director, Technology Solutions at PATH

Relationship likelihood: Strong

Manager at PATH

Relationship likelihood: Strong

President & Chief Executive Officer at Global Impact

Relationship likelihood: Strong

Chief Scientific Officer & Program Co-Lead, Diagnostics at PATH

Relationship likelihood: Strong

Chief People Officer at PATH

Relationship likelihood: Strong

Chief Strategic Partnerships & Philanthropy Officer at PATH

Relationship likelihood: Strong

Global Head, Malaria, Path Center for Vaccine Innovation & Access (Cvia) at PATH

Relationship likelihood: Strong

Chief of Accounting at PATH

Relationship likelihood: Strong

Paths to Kammerle Schneider
Potential Connections via
Relationship Science
You
Kammerle Schneider
Program Leader, Malaria & Neglected Tropical Diseases & Director, Center for Malaria Control & Elimination at PATH
Education
Career History
Program Leader, Malaria & Neglected Tropical Diseases & Director, Center for Malaria Control & Elimination
2011 - Current

Program for Appropriate Technology in Health provides social healthcare services. Its platform includes vaccines, drugs, diagnostics and devices. The firm offers treatment for malaria, pneumonia and diarrheal. The company was founded in 1977 and is headquartered in Seattle, WA.

Professional
Prior

International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY.

Assistant Director, Global Health Program
Prior

Council on Foreign Relations, Inc. provides and disseminates ideas on foreign policies to individuals, corporate members, journalists and policy makers. It operates a forum for government officials, students and other interested parties to study and discuss world issues and impact on American foreign policies. The company publishes Foreign Affairs, a magazine that comes out six times a year, along with books and studies by its own scholars. Council on Foreign Relations was founded in 1921 and is headquartered in New York City, NY.

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Kammerle Schneider. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Kammerle Schneider's profile does not indicate a business or promotional relationship of any kind between RelSci and Kammerle Schneider.